Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
INNV · against 596 other Healthcare companies listed in US-listed
Ranked #260 of 597 · scores higher than 57% of peers · safety percentile 57
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)44 peers with a safety percentile of 50–59, including INNV · Click a bar to see the companies
A mix: stronger beta, but weaker current ratio than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | INNV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 523 reported | 0.32× | 0.23× | 46% | 33% | |
| BetaLower is better · 556 reported | 0.15 | 0.95 | 92% | 33% | |
| Current ratioHigher is better · 600 reported | 1.05× | 3.91× | 7% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 256 | 191M USD | 57 | 38 | |
| 257 | 2.1B USD | 57 | 61 | |
| 258 | 2.4B USD | 57 | 20 | |
| 259 | 1.3B USD | 57 | 58 | |
| 260 | 1.2B USD | 57 | 49 | |
| 261 | 5.4B USD | 57 | 24 | |
| 262 | 8.4B USD | 56 | 67 | |
| 263 | 1.9B USD | 55 | 42 | |
| 264 | 9.4B USD | 55 | 70 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score